Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Cancer Biomarkers : Section a of Disease Markers|May 31, 2018
Up-regulation of regulatory T cells, CD200 and TIM3 expression in cytogenetically normal acute myeloid leukemiaAsmaa M Zahran, Mostafa F Mohammed Saleh, Mona M Sayed, et al.
Environmental Science and Pollution Research International|August 3, 2020
Genetic polymorphisms in XRCC1, OGG1, and XRCC3 DNA repair genes and DNA damage in radiotherapy workersAsmaa H M Soliman, Nasef N Zaki, Hala M Fathy, et al.
Plos One|February 22, 2021
Circulating microparticles and activated platelets as novel prognostic biomarkers in COVID-19; relation to cancerAsmaa M Zahran, Omnia El-Badawy, Wageeh A Ali, et al.
The Egyptian Journal of Immunology|January 3, 2019
Frequency and Implications of Natural Killer and Natural Killer T Cells in Hepatocellular CarcinomaAsmaa M Zahran, Mona M Abdel-Meguid, Ahmed M Ashmawy, et al.
Iranian Journal of Immunology : IJI|July 1, 2020
Prognostic Significance of Circulating CD28 Negative Suppressor T Cells and Memory B Cells in Patients with Breast CancerAsmaa M Zahran, Asmaa S Shaltout, Hussein Fakhry, et al.
Journal of Immunology Research|February 25, 2020
Upregulation of CD146 in Pediatric B-Cell Acute Lymphocytic Leukemia and Its Implications on Treatment OutcomesAsmaa M Zahran, Omnia El-Badawy, Khalid I Elsayh, et al.
Leukemia & Lymphoma|February 21, 2020
Monocytic myeloid-derived suppressor cells in chronic lymphocytic leukemia patients: a single center experienceAsmaa M Zahran, Sawsan M Moeen, Ahmad F Thabet, et al.
Oncotarget|October 23, 2018
Survival outcomes of CD34+CD38-LSCs and their expression of CD123 in adult AML patientsAsmaa M Zahran, Sanaa Shaker Aly, Amal Rayan, et al.
Pageof 3